// App-Quantinova.ai

854 : Developing 31-phosphorus magnetic resonance spectroscopy (31P-MRS) as an imaging biomarker to identify mitochondrial dysfunction in Parkinson’s disease

Researchers

Presenter

  • T. Payne

Principal Investigators

  • M. Sassani

  • S. Roscoe

  • S. Bradley

  • A. Anton

  • E. Reed

  • I. Wilkinson

  • H. Mortiboys

  • T. Jenkins

  • O. Bandmann

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • MDS-Unified Parkinson's Disease Rating Scale

Drug/Treatment

  • Adenosine-5'-triphosphate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved